Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients

Completed · Phase 4 · Has a placebo group

Conditions studied: Chronic Kidney Disease, Kidney Transplantation

In brief

People with kidney transplants often develop bone disease. One reason for bone disease may be overactivity of a gland in the neck called the parathyroid gland. Overactivity of the parathyroid gland may be caused by lack of Vitamin D in the body. It has recently been discovered that many patients with kidney transplants have low Vitamin D levels. The investigators are examining the effects of doxercalciferol on parathyroid hormone levels, proteinuria and bone turnover markers in people who have had a kidney transplant.

Key facts

Study ID
NCT00889629
Run by
Mariana Markell
People needed
39
Starts
2008-11-01
Expected to finish
2010-01-01
Last updated by the study team
2019-02-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.